BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23422777)

  • 1. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.
    Rampersaud EN; Klatte T; Bass G; Patard JJ; Bensaleh K; Böhm M; Allhoff EP; Cindolo L; De La Taille A; Mejean A; Soulie M; Bellec L; Christophe Bernhard J; Pfister C; Colombel M; Belldegrun AS; Pantuck AJ; George D
    Urol Oncol; 2014 Jan; 32(1):30.e9-13. PubMed ID: 23422777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC).
    Lee S; Jeon HG; Kwak C; Kim HH; Byun SS; Lee SE; Lee E
    BJU Int; 2012 Jul; 110(2 Pt 2):E28-33. PubMed ID: 22085161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
    Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
    Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
    Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
    Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of tumour multifocality in renal cell carcinoma.
    Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
    BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
    Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
    Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
    Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
    Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
    Gillett MD; Cheville JC; Karnes RJ; Lohse CM; Kwon ED; Leibovich BC; Zincke H; Blute ML
    J Urol; 2005 Jun; 173(6):1893-6. PubMed ID: 15879770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M; Brookman-Amissah S; Roigas J; Gilfrich CP; Pflanz S; Hoschke B; Gunia S
    Urol Oncol; 2010; 28(3):274-9. PubMed ID: 18805709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
    Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
    Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Han KR; Bui MH; Pantuck AJ; Dorey FJ; Figlin RA; Belldegrun A
    Cancer; 2003 Dec; 98(12):2566-75. PubMed ID: 14669275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and gender related differences in renal cell carcinoma in a European cohort.
    Hew MN; Zonneveld R; Kümmerlin IP; Opondo D; de la Rosette JJ; Laguna MP
    J Urol; 2012 Jul; 188(1):33-8. PubMed ID: 22578731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
    Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
    Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
    Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
    Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.